The Changing Pharma eDetailing Landscape
A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.
Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!
No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages.
Physicians Are Concerned About Pharma Support of CME, But Are Unwilling to Pay Their...
Talk about having your cake and eating it too! Commercial funding of continuing medical education (CME) and the potential for bias appear to concern many physicians, yet only a TINY MINORITY (7%) are willing to pay registration fees to eliminate or offset commercial funding sources, according to a report in the May 9, 2011, issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions
An anonymous poster to CafePharma described what the
Pharma Marketing News Vol. 10, No. 10: 8 June 2011
Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.
The Pharmaguy Social Media Timeline&trade: A Record of Social Media Events Impacting the Pharmaceutical...
The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application.
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Pharma Marketing News Vol. 10, No. 7: 15 April 2011
Welcome to Volume 10, Issue #7 (15 APRIL 2011) of Pharma Marketing News.
FDA’s Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!
This just in: FDA Won't Issue Specific Guidance for Youtube, Facebook, or Twitter. Claims These Media Are Just Passing Fads! Now Back to Your Regularly-Scheduled TV Ad.
Pharma YouTube Patient Videos Lack Transparency
Pharma social networking sites like Facebook and YouTube may lack patient-centered information and can also be sources of misleading information that could potentially do more harm than good.
